Logo image
Sign in
Back
Use of cough and cold medications in severe bronchiolitis before and after a health advisory warning against their use
Journal article   Peer reviewed

Use of cough and cold medications in severe bronchiolitis before and after a health advisory warning against their use

K. O'Donnell, J. M. Mansbach, F. LoVecchio, J. Cheng, P. A. Piedra, S. Clark, A. F. Sullivan and C. A. Camargo
Journal of Pediatrics, Vol.167(1), p.196
2015
DOI: https://doi.org/10.1016/j.jpeds.2015.03.037

Abstract

antitussive agent decongestive agent expectorant agent non prescription drug Article bronchiolitis child disease severity drug use female food and drug administration hospital patient human male multicenter study priority journal age clinical trial common cold Cough drug recall epidemiology infant mother prospective study severity of illness index smoking United States Age Factors Antitussive Agents Expectorants Humans Mothers Nasal Decongestants Nonprescription Drugs Prospective Studies Safety-Based Drug Withdrawals United States Food and Drug Administration
We compared the use of cough and cold medications in 2 multicenter studies of young children hospitalized with bronchiolitis before and after the 2008 Food and Drug Administration cough and cold medications advisory. Although cough and cold medication use decreased after the advisory, nearly 20% of children age 12-23.9 months with severe bronchiolitis received cough and cold medications. © 2015 Elsevier Inc.
url
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84937513251&doi=10.1016%2fj.jpeds.2015.03.037&partnerID=40&md5=a16b9caa40e49f4998b2dddfdbe694d8View

Metrics

1 Record Views

Details